Optivise Advisory Services LLC Amgen Inc Transaction History
Optivise Advisory Services LLC
- $168 Billion
- Q3 2025
A detailed history of Optivise Advisory Services LLC transactions in Amgen Inc stock. As of the latest transaction made, Optivise Advisory Services LLC holds 752 shares of AMGN stock, worth $222,449. This represents 0.13% of its overall portfolio holdings.
Number of Shares
752
Previous 908
17.18%
Holding current value
$222,449
Previous $254 Million
16.31%
% of portfolio
0.13%
Previous 0.13%
Shares
6 transactions
Others Institutions Holding AMGN
# of Institutions
3,282Shares Held
441MCall Options Held
6.14MPut Options Held
7.25M-
Vanguard Group Inc Valley Forge, PA53.7MShares$15.9 Billion0.25% of portfolio
-
Black Rock Inc. New York, NY46MShares$13.6 Billion0.33% of portfolio
-
State Street Corp Boston, MA29.4MShares$8.68 Billion0.32% of portfolio
-
Capital International Investors Los Angeles, CA18.9MShares$5.59 Billion0.95% of portfolio
-
Capital World Investors Los Angeles, CA16.9MShares$4.99 Billion0.71% of portfolio
About AMGEN INC
- Ticker AMGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 534,931,008
- Market Cap $158B
- Description
- Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...